Tejnaksh Healthcare Limited (BOM:539428)
India · Delayed Price · Currency is INR 13.53
-0.19 (-1.38%)
At close: Jul 31, 2026
Tejnaksh Healthcare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 275 | 242 | 426 | 470 | 700 | 1,711 | |
Market Cap Growth | -27.96% | -43.14% | -9.41% | -32.78% | -59.10% | 131.46% |
Enterprise Value | 262 | 240 | 438 | 492 | 736 | 1,763 |
Last Close Price | 13.53 | 11.93 | 20.98 | 23.16 | 34.45 | 84.25 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 22.18 | 19.73 | 18.31 | 26.49 | 41.59 | 62.83 |
PS Ratio | 2.55 | 2.25 | 3.27 | 3.84 | 5.90 | 13.43 |
PB Ratio | 0.99 | 0.88 | 1.61 | 1.94 | 3.12 | 8.31 |
P/TBV Ratio | 1.16 | 1.02 | 1.90 | 2.48 | 4.04 | 10.90 |
P/FCF Ratio | 22.88 | 20.18 | 314.76 | 14.25 | 53.99 | 1310.43 |
P/OCF Ratio | 16.02 | 14.12 | 111.19 | 11.74 | 32.97 | 18.59 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 2.43 | 2.22 | 3.36 | 4.01 | 6.20 | 13.84 |
EV/EBITDA Ratio | 9.43 | 8.64 | 10.46 | 13.36 | 19.33 | 36.52 |
EV/EBIT Ratio | 19.42 | 17.79 | 13.31 | 17.59 | 24.90 | 42.00 |
EV/FCF Ratio | 21.81 | 19.98 | 323.18 | 14.90 | 56.76 | 1349.73 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.01 | 0.01 | 0.04 | 0.20 | 0.29 | 0.34 |
Debt / EBITDA Ratio | 0.09 | 0.09 | 0.25 | 1.29 | 1.68 | 1.44 |
Debt / FCF Ratio | 0.21 | 0.21 | 7.78 | 1.45 | 4.95 | 53.59 |
Net Debt / Equity Ratio | -0.06 | -0.06 | -0.03 | 0.02 | 0.15 | 0.19 |
Net Debt / EBITDA Ratio | -0.64 | -0.64 | -0.18 | 0.15 | 0.86 | 0.83 |
Net Debt / FCF Ratio | -1.48 | -1.48 | -5.46 | 0.16 | 2.54 | 30.62 |
Asset Turnover | 0.36 | 0.36 | 0.42 | 0.39 | 0.39 | 0.47 |
Inventory Turnover | 2.97 | 2.97 | 4.49 | 4.00 | 4.51 | 4.29 |
Quick Ratio | 6.69 | 6.69 | 3.35 | 3.13 | 3.02 | 2.15 |
Current Ratio | 8.45 | 8.45 | 5.29 | 3.86 | 3.82 | 2.94 |
Return on Equity (ROE) | 4.37% | 4.37% | 8.81% | 7.57% | 8.33% | 14.66% |
Return on Assets (ROA) | 2.79% | 2.79% | 6.67% | 5.59% | 6.07% | 9.68% |
Return on Invested Capital (ROIC) | 3.72% | 3.75% | 9.11% | 8.24% | 8.38% | 13.63% |
Return on Capital Employed (ROCE) | 4.60% | 4.60% | 11.30% | 9.40% | 10.00% | 15.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 4.47% | 5.07% | 5.46% | 3.77% | 2.40% | 1.59% |
FCF Yield | 4.37% | 4.96% | 0.32% | 7.02% | 1.85% | 0.08% |
Buyback Yield / Dilution | 0.88% | 0.88% | - | - | - | - |